Pan-cancer population pharmacokinetics and exposure-safety and -efficacy analyses of atezolizumab in patients with high tumor mutational burden. - Shemesh CS; Chan P; Legrand FA; Shames DS; Das Thakur M; Shi J; Bailey L; Vadhavkar S; He X; Zhang W; Bruno R (Pharmacology research & perspectives, 2020)